Drugs / Bacteriophage Treatment
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07619924 | Jan 2025 → Oct 2027 expected | — | First Affiliated Hospital Xi'an Jiaotong University | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacteriophage Treatment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07619924 ↗ |
| Modality | Other / unclassified | “Bacteriophage (phage) therapy, which uses lytic viruses as antimicrobials” PMID 40301561 ↗ Apr 2025 |
| Route | Topical | “topical application of phage cocktails to the infected site” NCT07619924 ↗ |